CDP
COPT Defense Properties
REIT - Office
Market Cap$3.60B
5Y Perf.+27.1%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
CDP vs DEA vs GMRE vs PDM
Revenue, margins, valuation, and 5-year total return — side by side.
DEA
Easterly Government Properties, Inc.
REIT - Office
Market Cap$1.08B
5Y Perf.-62.8%
GMRE
Global Medical REIT Inc.
REIT - Healthcare Facilities
Market Cap$94M
5Y Perf.-35.4%
PDM
Piedmont Office Realty Trust, Inc.
REIT - Office
Market Cap$1.06B
5Y Perf.-49.3%
CDP vs DEA vs GMRE vs PDM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CDP | DEA | GMRE | PDM |
|---|---|---|---|---|
| Industry | REIT - Office | REIT - Office | REIT - Healthcare Facilities | REIT - Office |
| Market Cap | $3.60B | $1.08B | $94M | $1.06B |
| Revenue (TTM) | $777M | $344M | $148M | $422M |
| Net Income (TTM) | $156M | $15M | $2M | $-86M |
| Gross Margin | 31.9% | 49.7% | 68.8% | 19.1% |
| Operating Margin | 30.1% | 24.9% | 24.9% | 13.9% |
| Forward P/E | 23.7x | 69.5x | 595.7x | — |
| Total Debt | $2.81B | $1.68B | $654M | $2.27B |
| Cash & Equiv. | $275M | $23M | $7M | $731K |
CDP vs DEA vs GMRE vs PDM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CDP
DEA
GMRE
PDM
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| COPT Defense Proper… (CDP) | 100 | 127.1 | +27.1% |
| Easterly Government… (DEA) | 100 | 37.2 | -62.8% |
| Global Medical REIT… (GMRE) | 100 | 64.6 | -35.4% |
| Piedmont Office Rea… (PDM) | 100 | 50.7 | -49.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CDP vs DEA vs GMRE vs PDM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: CDP leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Easterly Government Properties, Inc. is the stronger pick specifically for growth and revenue expansion. GMRE and PDM also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
CDP
COPT Defense Properties
The Real Estate Income Play
CDP carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.37, current ratio 1.64x
- Beta 0.37, yield 3.8%, current ratio 1.64x
- Better valuation composite
- 20.1% margin vs PDM's -20.5%
Best for: sleep-well-at-night and defensive
DEA
Easterly Government Properties, Inc.
The Real Estate Income Play
DEA is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 11.3%, EPS growth -37.0%, 3Y rev CAGR 4.6%
- 11.3% FFO/revenue growth vs GMRE's -1.8%
Best for: growth exposure
GMRE
Global Medical REIT Inc.
The Real Estate Income Play
GMRE is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- 308.1% 10Y total return vs CDP's 60.4%
- 63.5% yield, 5-year raise streak, vs CDP's 3.8%
Best for: income & stability and long-term compounding
PDM
Piedmont Office Realty Trust, Inc.
The Real Estate Income Play
PDM is the clearest fit if your priority is momentum.
- +29.8% vs GMRE's -0.3%
Best for: momentum
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | DEA | 11.3% FFO/revenue growth vs GMRE's -1.8% |
| Value | CDP | Better valuation composite |
| Quality / Margins | CDP | 20.1% margin vs PDM's -20.5% |
| Stability / Safety | CDP | Beta 0.37 vs PDM's 1.08 |
| Dividends | GMRE | 63.5% yield, 5-year raise streak, vs CDP's 3.8% |
| Momentum (1Y) | PDM | +29.8% vs GMRE's -0.3% |
| Efficiency (ROA) | CDP | 3.5% ROA vs PDM's -2.2%, ROIC 4.3% vs 1.5% |
CDP vs DEA vs GMRE vs PDM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
Segment breakdown not available.
FY 2025
CDP vs DEA vs GMRE vs PDM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCDPLAGGINGDEA
Who Leads Where
CDP leads in 3 of 6 categories
GMRE leads 2 • PDM leads 1 • DEA leads 0
Explore the data ↓DEAEasterly Government P…
0leads
PDMPiedmont Office Realt…
1leads
GMREGlobal Medical REIT I…
2leads
CDPCOPT Defense Properti…
3leads
6 Total Categories
CATEGORYLEADERvs GMREvs PDMMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CDP3/6
Valuation MetricsMultiples, price ratios, and targets
GMRE3/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CDP6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
PDM3/6
Risk & VolatilityBeta, volatility, and downside exposure
CDP2/2
Analyst OutlookRatings, price targets, and dividends
GMRE2/2
Income & Cash Flow (Last 12 Months)
CDP leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CDP is the larger business by revenue, generating $777M annually — 5.2x GMRE's $148M. CDP is the more profitable business, keeping 20.1% of every revenue dollar as net income compared to PDM's -20.5%. On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CDPCOPT Defense Prop… | DEAEasterly Governme… | GMREGlobal Medical RE… | PDMPiedmont Office R… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $777M | $344M | $148M | $422M |
| EBITDAEarnings before interest/tax | $399M | $203M | $95M | $229M |
| Net IncomeAfter-tax profit | $156M | $15M | $2M | -$86M |
| Free Cash FlowCash after capex | $215M | $262M | $19M | $47M |
| Gross MarginGross profit ÷ Revenue | +31.9% | +49.7% | +68.8% | +19.1% |
| Operating MarginEBIT ÷ Revenue | +30.1% | +24.9% | +24.9% | +13.9% |
| Net MarginNet income ÷ Revenue | +20.1% | +4.3% | +1.7% | -20.5% |
| FCF MarginFCF ÷ Revenue | +27.7% | +76.2% | +12.6% | +11.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.8% | +10.6% | +18.7% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.7% | -55.4% | -166.2% | -23.0% |
CDP leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
GMRE leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 23.7x trailing earnings, CDP trades at a 79% valuation discount to GMRE's 115.3x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than CDP's 15.6x.
| Metric | CDPCOPT Defense Prop… | DEAEasterly Governme… | GMREGlobal Medical RE… | PDMPiedmont Office R… |
|---|---|---|---|---|
| Market CapShares × price | $3.6B | $1.1B | $94M | $1.1B |
| Enterprise ValueMkt cap + debt − cash | $6.1B | $2.7B | $741M | $3.3B |
| Trailing P/EPrice ÷ TTM EPS | 23.68x | 80.31x | 115.29x | -12.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.69x | 69.52x | 595.67x | — |
| PEG RatioP/E ÷ EPS growth rate | 2.62x | — | — | — |
| EV / EBITDAEnterprise value multiple | 15.64x | 13.85x | 8.35x | 10.86x |
| Price / SalesMarket cap ÷ Revenue | 4.71x | 3.21x | 0.68x | 1.87x |
| Price / BookPrice ÷ Book value/share | 2.26x | 0.77x | 0.17x | 0.70x |
| Price / FCFMarket cap ÷ FCF | 14.18x | 4.16x | — | — |
GMRE leads this category, winning 3 of 6 comparable metrics.
Profitability & Efficiency
CDP leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CDP delivers a 9.9% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-6 for PDM. GMRE carries lower financial leverage with a 1.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to CDP's 1.77x. On the Piotroski fundamental quality scale (0–9), CDP scores 5/9 vs GMRE's 4/9, reflecting solid financial health.
| Metric | CDPCOPT Defense Prop… | DEAEasterly Governme… | GMREGlobal Medical RE… | PDMPiedmont Office R… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.9% | +1.1% | +0.5% | -5.7% |
| ROA (TTM)Return on assets | +3.5% | +0.4% | +0.2% | -2.2% |
| ROICReturn on invested capital | +4.3% | +2.1% | +2.0% | +1.5% |
| ROCEReturn on capital employed | +5.6% | +3.6% | +5.3% | +2.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 4 | 5 |
| Debt / EquityFinancial leverage | 1.77x | 1.23x | 1.18x | 1.52x |
| Net DebtTotal debt minus cash | $2.5B | $1.7B | $647M | $2.3B |
| Cash & Equiv.Liquid assets | $275M | $23M | $7M | $731,000 |
| Total DebtShort + long-term debt | $2.8B | $1.7B | $654M | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.80x | 1.18x | 1.14x | 0.35x |
CDP leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
PDM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CDP five years ago would be worth $13,490 today (with dividends reinvested), compared to $6,046 for PDM. Over the past 12 months, PDM leads with a +29.8% total return vs GMRE's -0.3%. The 3-year compound annual growth rate (CAGR) favors PDM at 13.7% vs DEA's -6.2% — a key indicator of consistent wealth creation.
| Metric | CDPCOPT Defense Prop… | DEAEasterly Governme… | GMREGlobal Medical RE… | PDMPiedmont Office R… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | +16.6% | +11.4% | +6.9% | +1.9% |
| 1-Year ReturnPast 12 months | +24.6% | +21.4% | -0.3% | +29.8% |
| 3-Year ReturnCumulative with dividends | +46.1% | -17.4% | +5.6% | +46.9% |
| 5-Year ReturnCumulative with dividends | +34.9% | -37.9% | -19.8% | -39.5% |
| 10-Year ReturnCumulative with dividends | +60.4% | -10.5% | +308.1% | -23.2% |
| CAGR (3Y)Annualised 3-year return | +13.5% | -6.2% | +1.8% | +13.7% |
PDM leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
CDP leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CDP is the less volatile stock with a 0.37 beta — it tends to amplify market swings less than PDM's 1.08 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CDP currently trades 95.3% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CDPCOPT Defense Prop… | DEAEasterly Governme… | GMREGlobal Medical RE… | PDMPiedmont Office R… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.37x | 0.51x | 0.48x | 1.08x |
| 52-Week HighHighest price in past year | $33.29 | $24.94 | $39.93 | $9.19 |
| 52-Week LowLowest price in past year | $25.99 | $19.82 | $29.05 | $6.32 |
| % of 52W HighCurrent price vs 52-week peak | +95.3% | +93.4% | +89.5% | +91.9% |
| RSI (14)Momentum oscillator 0–100 | 42.0 | 53.5 | 52.7 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 896K | 386K | 115K | 1.1M |
CDP leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
GMRE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CDP as "Buy", DEA as "Hold", GMRE as "Buy", PDM as "Hold". Consensus price targets imply 18.3% upside for PDM (target: $10) vs -29.5% for DEA (target: $16). For income investors, GMRE offers the higher dividend yield at 63.51% vs PDM's 2.94%.
| Metric | CDPCOPT Defense Prop… | DEAEasterly Governme… | GMREGlobal Medical RE… | PDMPiedmont Office R… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $36.00 | $16.41 | $40.00 | $10.00 |
| # AnalystsCovering analysts | 21 | 8 | 22 | 11 |
| Dividend YieldAnnual dividend ÷ price | +3.8% | +9.0% | +63.5% | +2.9% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 5 | 0 |
| Dividend / ShareAnnual DPS | $1.21 | $2.10 | $22.70 | $0.25 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
GMRE leads this category, winning 2 of 2 comparable metrics.
Key Takeaway
CDP leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GMRE leads in 2 (Valuation Metrics, Analyst Outlook).
Best OverallCOPT Defense Properties (CDP)Leads 3 of 6 categories
Loading custom metrics...
CDP vs DEA vs GMRE vs PDM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CDP or DEA or GMRE or PDM a better buy right now?
For growth investors, Easterly Government Properties, Inc.
(DEA) is the stronger pick with 11. 3% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). COPT Defense Properties (CDP) offers the better valuation at 23. 7x trailing P/E (23. 7x forward), making it the more compelling value choice. Analysts rate COPT Defense Properties (CDP) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CDP or DEA or GMRE or PDM?
On trailing P/E, COPT Defense Properties (CDP) is the cheapest at 23.
7x versus Global Medical REIT Inc. at 115. 3x. On forward P/E, COPT Defense Properties is actually cheaper at 23. 7x.
03Which is the better long-term investment — CDP or DEA or GMRE or PDM?
Over the past 5 years, COPT Defense Properties (CDP) delivered a total return of +34.
9%, compared to -39. 5% for Piedmont Office Realty Trust, Inc. (PDM). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus PDM's -23. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CDP or DEA or GMRE or PDM?
By beta (market sensitivity over 5 years), COPT Defense Properties (CDP) is the lower-risk stock at 0.
37β versus Piedmont Office Realty Trust, Inc. 's 1. 08β — meaning PDM is approximately 197% more volatile than CDP relative to the S&P 500. On balance sheet safety, Global Medical REIT Inc. (GMRE) carries a lower debt/equity ratio of 118% versus 177% for COPT Defense Properties — giving it more financial flexibility in a downturn.
05Which is growing faster — CDP or DEA or GMRE or PDM?
By revenue growth (latest reported year), Easterly Government Properties, Inc.
(DEA) is pulling ahead at 11. 3% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: COPT Defense Properties grew EPS 8. 9% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, GMRE leads at 6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CDP or DEA or GMRE or PDM?
COPT Defense Properties (CDP) is the more profitable company, earning 19.
9% net margin versus -14. 8% for Piedmont Office Realty Trust, Inc. — meaning it keeps 19. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CDP leads at 30. 2% versus 14. 1% for PDM. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CDP or DEA or GMRE or PDM more undervalued right now?
On forward earnings alone, COPT Defense Properties (CDP) trades at 23.
7x forward P/E versus 595. 7x for Global Medical REIT Inc. — 572. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PDM: 18. 3% to $10. 00.
08Which pays a better dividend — CDP or DEA or GMRE or PDM?
All stocks in this comparison pay dividends.
Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 2. 9% for Piedmont Office Realty Trust, Inc. (PDM).
09Is CDP or DEA or GMRE or PDM better for a retirement portfolio?
For long-horizon retirement investors, Global Medical REIT Inc.
(GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 63. 5% yield, +308. 1% 10Y return). Both have compounded well over 10 years (GMRE: +308. 1%, PDM: -23. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CDP and DEA and GMRE and PDM?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CDP is a small-cap income-oriented stock; DEA is a small-cap income-oriented stock; GMRE is a small-cap income-oriented stock; PDM is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(CDP: 6.8% · DEA: 10.6%)Net Margin>
%
(CDP: 20.1% · DEA: 4.3%)P/E Ratio<
x
(CDP: 23.7x · DEA: 80.3x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.